Teachers Advisors’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$6.46M Buy
264,496
+24,605
+10% +$644K 0.01% 1244
2018
Q4
$6.22M Buy
239,891
+2,628
+1% +$72.3K 0.01% 1182
2018
Q3
$7.51M Buy
237,263
+7,724
+3% +$288K 0.01% 1215
2018
Q2
$8.92M Buy
229,539
+24,726
+12% +$787K 0.01% 1134
2018
Q1
$5.65M Buy
204,813
+121,881
+147% +$2.76M 0.01% 1278
2017
Q4
$1.5M Hold
82,932
﹤0.01% 2024
2017
Q3
$1.34M Hold
82,932
﹤0.01% 2076
2017
Q2
$1.15M Buy
82,932
+13,212
+19% +$191K ﹤0.01% 2147
2017
Q1
$1.05M Buy
69,720
+11,862
+21% +$164K ﹤0.01% 2162
2016
Q4
$758K Buy
57,858
+1,924
+3% +$30.2K ﹤0.01% 2323
2016
Q3
$964K Hold
55,934
﹤0.01% 2086
2016
Q2
$1.01M Sell
55,934
-2,539
-4% -$49.6K ﹤0.01% 2029
2016
Q1
$1.11M Sell
58,473
-94,619
-62% -$1.87M ﹤0.01% 1916
2015
Q4
$4.09M Buy
153,092
+973
+0.6% +$26K 0.01% 1219
2015
Q3
$3.71M Buy
152,119
+115,624
+317% +$3.85M 0.01% 1231
2015
Q2
$1.14M Sell
36,495
-551
-1% -$10.4K ﹤0.01% 2038
2015
Q1
$539K Buy
37,046
+5,453
+17% +$61.5K ﹤0.01% 2392
2014
Q4
$318K Buy
31,593
+5,572
+21% +$45.5K ﹤0.01% 2687
2014
Q3
$217K Hold
26,021
﹤0.01% 2844
2014
Q2
$321K Buy
+26,021
New +$311K ﹤0.01% 2701

Other funds holding HRTX

Teachers Advisors's HRTX Position: Q1 2019 in Review

Teachers Advisors increased its Heron Therapeutics (HRTX) stake by 10% in Q1 2019, buying an estimated $644K and bringing the position to 264,496 shares worth $6.46M. The position accounts for 0.01% of the portfolio, ranked #1244.

Teachers Advisors first reported a position in HRTX in Q2 2014 and has held it in 20 quarters since. The position peaked at $8.92M in Q2 2018. 198 funds tracked by Wall St. Rank hold HRTX as of Q1 2019.

  • Teachers Advisors held 264,496 shares of Heron Therapeutics worth $6.46M as of Q1 2019.
  • Teachers Advisors bought 24,605 Heron Therapeutics shares in Q1 2019, an estimated $644K.
  • Heron Therapeutics made up 0.01% of Teachers Advisors's portfolio in Q1 2019, its #1244 holding.
  • Teachers Advisors first reported a position in Heron Therapeutics in Q2 2014 and has held it in 20 quarters since.
  • Teachers Advisors's Heron Therapeutics position peaked at $8.92M in Q2 2018.
  • 198 funds tracked by Wall St. Rank held Heron Therapeutics as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.